RESEARCHER VERIFICATION:
Lionheart Peptides sells premium research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use – not for human or animal consumption.
All products on this website are sold strictly for Research Use Only – not for human, animal, clinical, or therapeutic use. Customers are responsible for compliant, properly authorized handling of all products and associated risks.
TB-500
Regular Price$67.20
Synthetic peptide for tissue repair and cellular migration research
TB-500 is a synthetic peptide based on Thymosin Beta-4 and is investigated in laboratory research involving tissue repair, cellular migration, angiogenesis, and inflammatory pathways. Research examines its role in processes associated with tendons, ligaments, muscle, and other tissue systems.
Key Product Facts
- CAS Number: 885340-08-9
- Molecular Formula: C38H68N10O14
- Molecular Weight: 889.01 g/mol
- Appearance: White Powder
- Storage: 2–8°C
- Purity: ≥99% stated purity
We accept

About TB-500
TB-500 is a synthetic peptide based on the naturally occurring peptide Thymosin Beta-4. Laboratory research investigates TB-500 in relation to cellular migration, angiogenesis, tissue repair pathways, and inflammatory processes.
Key Highlights
- Synthetic peptide based on Thymosin Beta-4
- Studied in tissue repair research
- Investigated in cellular migration pathways
- Research involving angiogenesis and blood vessel formation
- Studied in inflammatory pathways
- Research involving tendon, ligament, and muscle tissue
- 10mg size
- ≥99% stated purity
- White powder
- Storage at 2–8°C
Additional Details
Specifications
CAS Number: 885340-08-9
Molecular Formula: C38H68N10O14
Molecular Weight: 889.01 g/mol
Appearance: White Powder
Storage: 2–8°C
Purity: ≥99%
What’s Included
- 1 vial of TB-500
- 10mg
Research Use Notice
All products featured here are intended exclusively for research and development purposes. They are not designed for human or animal consumption and have not undergone evaluation by the U.S. Food and Drug Administration.

